颈动脉血运重建后脑过度灌注综合征:预测因素与并发症
基于血管质量倡议数据库2020至2023年行颈动脉内膜剥脱术、经股动脉颈动脉支架置入术或经颈动脉血运重建术的颈动脉狭窄患者,脑过度灌注综合征发生率为0.25%,经股动脉颈动脉支架置入术风险最高,未控制高血压使风险约翻倍,并开发了预测模型。
要点
- 经股动脉颈动脉支架置入术的脑过度灌注综合征发生率最高(0.78%),经颈动脉血运重建术与颈动脉内膜剥脱术相当。
- 未控制高血压与脑过度灌注综合征风险约增加2倍相关。
- 发生脑过度灌注综合征后,经股动脉颈动脉支架置入术的院内卒中及死亡风险均显著高于颈动脉内膜剥脱术。
核心结论
- 颈动脉血运重建方式显著影响脑过度灌注综合征及后续卒中与死亡风险,经股动脉颈动脉支架置入术风险最高。
- 未控制高血压与脑过度灌注综合征风险约增加2倍相关,强调严格控制血压的重要性。
- 基于术前因素建立了脑过度灌注综合征预测模型,前瞻性使用该风险计算器可能有助于术后监测。
研究设计与样本
- 回顾性分析血管质量倡议数据库中2020至2023年因颈动脉狭窄行颈动脉内膜剥脱术、经股动脉颈动脉支架置入术或经颈动脉血运重建术的所有患者。
- 采用多变量逻辑回归识别脑过度灌注综合征预测因素并开发风险评分计算器,比较三种血运重建技术后脑过度灌注综合征患者的卒中与死亡率。
主要发现
- 最终队列包括颈动脉内膜剥脱术59130例(53%)、经股动脉颈动脉支架置入术14064例(13%)、经颈动脉血运重建术37565例(34%)。
- 脑过度灌注综合征共281例(0.25%),经股动脉颈动脉支架置入术发生率最高(0.78% vs 0.22% vs 0.15%;P < 0.001)。
- 校正潜在混杂因素后,经股动脉颈动脉支架置入术较颈动脉内膜剥脱术风险约高3倍(aOR=2.87 [95%CI: 1.65-4.9] P < 0.001),经颈动脉血运重建术与颈动脉内膜剥脱术相当。
- 其他预测因素包括未控制高血压、胰岛素依赖型糖尿病、症状性状态、既往颈动脉手术、紧急干预和术后降压药物。
- 发生脑过度灌注综合征的患者中,经股动脉颈动脉支架置入术较颈动脉内膜剥脱术院内卒中风险高70%(aOR=1.7 [95%CI: 1.4-2] P < 0.001),院内死亡风险近3倍(aOR=2.9 [95%CI: 2.3-3.8] P < 0.001);经颈动脉血运重建术与颈动脉内膜剥脱术相当,但经颈动脉血运重建术后院内卒中风险略高(aOR=1.2 [95%CI: 1-1.3] P = 0.03)。
关键数值与推荐
- 脑过度灌注综合征预测模型C-statistic=0.8。
- 未控制高血压与脑过度灌注综合征风险约增加2倍相关。
临床怎么用
- 作者认为,基于术前因素的前瞻性风险计算器使用可能有助于术后监测。
- 作者强调未控制高血压与脑过度灌注综合征风险约增加2倍相关,强调严格控制血压的重要性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cerebral hyperperfusion syndrome (CHS) is a rare but serious complication following carotid artery revascularization. Considering the varying rates observed among carotid endarterectomy (CEA), Transfemoral Carotid Artery Stenting (TFCAS), and Transcarotid Artery Revascularization (TCAR), identifying the predictors and complications of CHS is essential for improving patient outcomes. This study utilizes a national database to investigate the predictors and complications of CHS following carotid revascularizations. METHODS: We conducted a retrospective analysis of all patients undergoing CEA, TFCAS, and TCAR for carotid artery stenosis in the Vascular Quality Initiative database from 2020 to 2023. Multivariate logistic regression was applied to identify CHS predictors, which were used to develop a risk score calculator. Moreover, we compared the stroke and mortality rates following CHS among the 3 revascularization techniques. RESULTS: The final cohort in our study included 59,130 (53%) CEAs, 14,064 (13%) TFCAS's, and 37,565 (34%) TCARs. There were 281 cases of CHS (0.25%), and TFCAS was associated with the highest rate of CHS (0.78% vs. 0.22% vs. 0.15%; P < 0.001). After adjusting for potential confounders, TFCAS was associated with almost 3-fold higher risk compared to CEA (adjusted odds ratio (aOR) = 2.87 [95% confidence interval (CI): 1.65-4.9] P < 0.001). On the other hand, TCAR was comparable to CEA. Other predictors of CHS included uncontrolled hypertension, insulin-dependent diabetes, symptomatic status, prior carotid procedure, urgent intervention, and postoperative blood pressure medication. These predictors were used to develop an interactive CHS risk calculator (C-statistic = 0.8). Among patients who developed CHS, TFCAS was associated with a 70% higher risk of inhospital stroke (aOR = 1.7 [95% CI: 1.4-2] P < 0.001) and almost triple the risk of inhospital death (aOR = 2.9 [95% CI: 2.3-3.8] P < 0.001). TCAR and CEA were comparable except for a slight risk of inhospital stroke after TCAR (aOR = 1.2 [95% CI: 1-1.3] P = 0.03). CONCLUSION: In this multi-institutional national study, we have demonstrated that the type of carotid revascularization significantly influences the risk of CHS and subsequent stroke and mortality, with TFCAS associated with the highest risk. Uncontrolled hypertension was associated with a 2-fold increased risk of CHS, underscoring the importance of tight blood pressure control. We were able to provide a prediction model for CHS based on preoperative factors. Prospective use of this risk calculator might benefit in postoperative monitoring.
引用
- Abdelkarim A, Hamouda M, Real M, et al. Cerebral Hyperperfusion Syndrome after Carotid Revascularization; Predictors and Complications. Ann Vasc Surg. 2025. PMID: 40044075. doi:10.1016/j.avsg.2025.02.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。